Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

AbbVie Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (149)
Cancellation by sponsor (70)
Australian Public Assessment Report (AusPAR) (21)
Prescription medicine registration (20)
Designation or determination (6)
Prescription medicine evaluation (4)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2024 (20)
2023 (27)
2022 (14)
2021 (14)
2020 (20)
2019 (25)
2018 (14)
2017 (29)
2016 (5)
2015 (19)
2014 (29)
2013 (4)
2012 (4)
2011 (4)
2010 (7)
2009 (4)
2008 (4)
2007 (1)
2006 (4)
2005 (4)
2003 (3)
2002 (2)
2001 (4)
1999 (1)
1998 (1)
1997 (1)
1996 (1)
1994 (2)
1991 (5)

Results for "[search-keyword]"

Search

Sponsor content

272 result(s) found, displaying 201 to 210

Abbvie Pty Ltd - Lubricant, eye (203205)

22 November 2012

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - Lubricant, eye.
AusPAR: Adalimumab (rch)

10 December 2015

Australian Public Assessment Report (AusPAR)
Abbvie Pty Ltd - Juvederm VOLUMA with Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic (196358)

5 April 2012

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - Juvederm VOLUMA with Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic.
LUCRIN XL DEPOT 6-MONTH leuprorelin acetate 30 mg powder for injection prefilled dual-chamber syringe Cancelled under s30(1)(c )

4 September 2015

Cancellation by sponsor

Requested by Abbvie Pty Ltd
Abbvie Pty Ltd - Needle, hypodermic (193150)

16 December 2011

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - Needle, hypodermic.
HUMIRA adalimumab (rch) 40mg solution for injection pre-filled syringe Cancelled under s30(1)(c) of the Act

3 June 2015

Cancellation by sponsor

Requested by Abbvie Pty Ltd
HUMIRA adalimumab (rch) 40mg solution for injection pre-filled pen Cancelled under s30(1)(c) of the Act

3 June 2015

Cancellation by sponsor

Requested by Abbvie Pty Ltd
HUMIRA adalimumab (rch) 20mg solution for injection pre-filled syringe Cancelled under s30(1)(c) of the Act

3 June 2015

Cancellation by sponsor

Requested by Abbvie Pty Ltd
Abbvie Pty Ltd - Lubricant, eye (188741)

1 September 2011

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - Lubricant, eye.
Abbvie Pty Ltd - Lubricant, eye (187407)

8 August 2011

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Abbvie Pty Ltd - Lubricant, eye.

Pages

First page
Previous page
…
Page 17
Page 18
Page 19
Page 20
Current page 21
Page 22
Page 23
Page 24
Page 25
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.